The invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof
for treating diseases and conditions mediated by positive allosteric modulation of the G-protein coupled metabotropic subtype 5 receptor (mGluR5), such as neurological and psychiatric disorders, for example schizophrenia. In addition, the invention relates to compositions containing the derivatives and processes for their preparation.
该发明提供了式(I)的化合物或其药学上可接受的盐,用于治疗通过正向变构调节G蛋白偶联代谢型亚型5受体(mGluR5)介导的疾病和状况,例如神经和精神障碍,例如精神分裂症。此外,该发明涉及含有这些衍
生物的组合物以及其制备方法。